FDA approves Bayer’s Finerenone for new indication in patients with HF and LVEF of ?40%
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
To streamline complex medical writing workflows with GenAI
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The company showcased three core programs developed through this platform
Subscribe To Our Newsletter & Stay Updated